Show simple item record

dc.contributor.authorDunning, DL
dc.contributor.authorAhmed, S
dc.contributor.authorFoulkes, L
dc.contributor.authorGriffin, C
dc.contributor.authorGriffiths, K
dc.contributor.authorLeung, JT
dc.contributor.authorParker, J
dc.contributor.authorPiera Pi-Sunyer, B
dc.contributor.authorSakhardande, A
dc.contributor.authorBennett, M
dc.contributor.authorHaag, C
dc.contributor.authorMontero-Marin, J
dc.contributor.authorPackman, D
dc.contributor.authorVainre, M
dc.contributor.authorWatson, P
dc.contributor.authorMYRIAD team
dc.contributor.authorKuyken, W
dc.contributor.authorWilliams, JMG
dc.contributor.authorUkoumunne, O
dc.contributor.authorBlakemore, S-J
dc.contributor.authorDalgleish, T
dc.date.accessioned2022-07-01T12:03:47Z
dc.date.issued2022-07-12
dc.date.updated2022-07-01T10:24:34Z
dc.description.abstractBackground: Previous research suggests that mindfulness training (MT) appears effective at improving mental health in young people. MT is proposed to work through improving executive control in affectively-laden contexts. However, it is unclear whether MT improves such control in young people. MT appears to mitigate mental health difficulties during periods of stress, but any mitigating effects against COVID-related difficulties remain unexamined. Objective: To evaluate whether MT (intervention), versus Psycho-Education (Psy-Ed; control), implemented in after-school classes: (i) improves affective executive control; and/or (ii) mitigates negative mental health impacts from the COVID-19 pandemic. Methods: A parallel randomised controlled trial (RCT) was conducted (Registration: https://osf.io/d6y9q/; Funding: Wellcome [WT104908/Z/14/Z, WT107496/Z/15/Z]). Four hundred and sixty students aged 11-16 were recruited and randomised 1:1 to either MT (N=235) or Psy-Ed (N=225) and assessed pre- and post-intervention on experimental tasks and self-report inventories of affective executive control. The RCT was then extended to evaluate protective functions of MT on mental health assessed after the first UK COVID-19 lockdown. Findings: Results provided no evidence that the version of MT used here improved affective executive control after training or mitigated negative consequences on mental health of the COVID-19 pandemic relative to Psy-Ed. No adverse events were reported. Conclusions: There is no evidence that MT improves affective control or downstream mental health of young people during stressful periods. Clinical implications: We need to identify interventions that can enhance affective control and thereby young people’s mental health.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipISCIIIen_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationVol. 25, pp. 110 - 116en_GB
dc.identifier.doi10.1136/ebmental-2022-300460
dc.identifier.grantnumberWT104908/Z/14/Zen_GB
dc.identifier.grantnumberWT107496/Z/15/Zen_GB
dc.identifier.grantnumberCP21/00080en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130114
dc.identifierORCID: 0000-0002-0551-9157 (Ukoumunne, Obi)
dc.language.isoenen_GB
dc.publisherBMJ Publishing Group / Royal College of Psychiatrists / The British Psychological Societyen_GB
dc.rights© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
dc.subjectmindfulnessen_GB
dc.subjectmental healthen_GB
dc.subjectadolescenceen_GB
dc.subjectCovid-19en_GB
dc.subjectlockdownsen_GB
dc.subjectsocial isolationen_GB
dc.subjectaffective controlen_GB
dc.subjectexecutive functionen_GB
dc.titleThe impact of mindfulness training in early adolescence on affective executive control, and on later mental health during the COVID-19 pandemic: A randomised controlled trialen_GB
dc.typeArticleen_GB
dc.date.available2022-07-01T12:03:47Z
dc.identifier.issn1362-0347
dc.descriptionThis is the final version. Available on open access from BMJ Publishing Group via the DOI in this recorden_GB
dc.identifier.eissn1468-960X
dc.identifier.journalEvidence-Based Mental Healthen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-06-15
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-06-15
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-07-01T10:24:36Z
refterms.versionFCDAM
refterms.dateFOA2022-08-09T14:52:06Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.